184 related articles for article (PubMed ID: 22785114)
1. Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study.
Stallone G; Infante B; Grandaliano G; Bristogiannis C; Macarini L; Mezzopane D; Bruno F; Montemurno E; Schirinzi A; Sabbatini M; Pisani A; Tataranni T; Schena FP; Gesualdo L
Nephrol Dial Transplant; 2012 Sep; 27(9):3560-7. PubMed ID: 22785114
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
3. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus for treatment of autosomal-dominant polycystic kidney disease: a meta-analysis of randomized controlled trials.
Liu YM; Shao YQ; He Q
Transplant Proc; 2014; 46(1):66-74. PubMed ID: 24507028
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin and autosomal dominant polycystic kidney disease.
Wüthrich RP; Serra AL
Transplant Proc; 2009; 41(6 Suppl):S18-20. PubMed ID: 19651290
[TBL] [Abstract][Full Text] [Related]
6. Impact of mammalian target of rapamycin inhibition on autosomal-dominant polycystic kidney disease.
Wüthrich RP; Kistler AD; Serra AL
Transplant Proc; 2010 Nov; 42(9 Suppl):S44-6. PubMed ID: 21095452
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease.
Serra AL; Kistler AD; Poster D; Krauer F; Senn O; Raina S; Pavik I; Rentsch K; Regeniter A; Weishaupt D; Wüthrich RP
Nephrol Dial Transplant; 2009 Nov; 24(11):3334-42. PubMed ID: 19525519
[TBL] [Abstract][Full Text] [Related]
8. Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.
Ruggenenti P; Gentile G; Perico N; Perna A; Barcella L; Trillini M; Cortinovis M; Ferrer Siles CP; Reyes Loaeza JA; Aparicio MC; Fasolini G; Gaspari F; Martinetti D; Carrara F; Rubis N; Prandini S; Caroli A; Sharma K; Antiga L; Remuzzi A; Remuzzi G;
Clin J Am Soc Nephrol; 2016 May; 11(5):785-794. PubMed ID: 26912555
[TBL] [Abstract][Full Text] [Related]
9. [Autosomal dominant polycystic kidney disease (ADPKD): rapamycin as a new treatment option].
Serra AL; Wüthrich RP
Praxis (Bern 1994); 2009 Dec; 98(25):1511-6. PubMed ID: 20013687
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant polycystic kidney disease: new treatment options and how to test their efficacy.
Wüthrich RP; Serra AL; Kistler AD
Kidney Blood Press Res; 2009; 32(5):380-7. PubMed ID: 19887826
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.
Serra AL; Poster D; Kistler AD; Krauer F; Raina S; Young J; Rentsch KM; Spanaus KS; Senn O; Kristanto P; Scheffel H; Weishaupt D; Wüthrich RP
N Engl J Med; 2010 Aug; 363(9):820-9. PubMed ID: 20581391
[TBL] [Abstract][Full Text] [Related]
12. Everolimus in patients with autosomal dominant polycystic kidney disease.
Walz G; Budde K; Mannaa M; Nürnberger J; Wanner C; Sommerer C; Kunzendorf U; Banas B; Hörl WH; Obermüller N; Arns W; Pavenstädt H; Gaedeke J; Büchert M; May C; Gschaidmeier H; Kramer S; Eckardt KU
N Engl J Med; 2010 Aug; 363(9):830-40. PubMed ID: 20581392
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with mammalian target of rapamycin inhibitor does not benefit patients with autosomal dominant polycystic kidney disease: a meta-analysis.
Xue C; Dai B; Mei C
Nephron Clin Pract; 2013; 124(1-2):10-6. PubMed ID: 24022660
[TBL] [Abstract][Full Text] [Related]
14. Concomitant use of rapamycin and rosiglitazone delays the progression of polycystic kidney disease in Han:SPRD rats: a study of the mechanism of action.
Liu C; Li H; Gao X; Yang M; Yuan L; Fu L; Wang X; Mei C
Am J Physiol Renal Physiol; 2018 May; 314(5):F844-F854. PubMed ID: 26911848
[TBL] [Abstract][Full Text] [Related]
15. Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study.
Braun WE; Schold JD; Stephany BR; Spirko RA; Herts BR
Clin J Am Soc Nephrol; 2014 May; 9(5):881-8. PubMed ID: 24721888
[TBL] [Abstract][Full Text] [Related]
16. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease.
Zafar I; Ravichandran K; Belibi FA; Doctor RB; Edelstein CL
Kidney Int; 2010 Oct; 78(8):754-61. PubMed ID: 20686448
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus produced S-shaped effect on adult polycystic kidneys after 2-year treatment.
Soliman A; Zamil S; Lotfy A; Ismail E
Transplant Proc; 2012 Dec; 44(10):2936-9. PubMed ID: 23195001
[TBL] [Abstract][Full Text] [Related]
19. Monitoring biological action of rapamycin in renal transplantation.
Leogrande D; Teutonico A; Ranieri E; Saldarelli M; Gesualdo L; Schena FP; Di Paolo S
Am J Kidney Dis; 2007 Aug; 50(2):314-25. PubMed ID: 17660033
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease.
Ulusoy S; Ozkan G; Orem C; Kaynar K; Koşucu P; Kiriş A
Ren Fail; 2010; 32(8):913-7. PubMed ID: 20722556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
